Home Healthcare Pharmaceuticals Smart Insulin or Glucose Responsive Insulin Market

Smart Insulin or Glucose Responsive Insulin Market Size, Share & Trends Analysis Report By Delivery Device (Smart Insulin Pens, Smart Insulin Pumps), By Disease (Type 1 Diabetes, Type 2 Diabetes), By End-User (Rapid-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Short-Acting Insulin, Premixed-Type Insulin) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Smart Insulin or Glucose Responsive Insulin Market, By Delivery Device 2022-2034 (USD MILLION/ Units)
    1. Smart Insulin Pens
    2. Smart Insulin Pumps
  2. Smart Insulin or Glucose Responsive Insulin Market, By Disease 2022-2034 (USD MILLION/ Units)
    1. Type 1 Diabetes
    2. Type 2 Diabetes
  3. Smart Insulin or Glucose Responsive Insulin Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Rapid-Acting Insulin
    2. Intermediate-Acting Insulin
    3. Long-Acting Insulin
    4. Short-Acting Insulin
    5. Premixed-Type Insulin
  4. Regional Smart Insulin or Glucose Responsive Insulin Market
    1. North America
      1. North America Smart Insulin or Glucose Responsive Insulin Market By Delivery Device 2022-2034 (USD MILLION/ Units)
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
      2. North America Smart Insulin or Glucose Responsive Insulin Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. North America Smart Insulin or Glucose Responsive Insulin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rapid-Acting Insulin
        2. Intermediate-Acting Insulin
        3. Long-Acting Insulin
        4. Short-Acting Insulin
        5. Premixed-Type Insulin
      4. U.S.
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      5. Canada
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
    2. Europe
      1. Europe Smart Insulin or Glucose Responsive Insulin Market By Delivery Device 2022-2034 (USD MILLION/ Units)
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
      2. Europe Smart Insulin or Glucose Responsive Insulin Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. Europe Smart Insulin or Glucose Responsive Insulin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rapid-Acting Insulin
        2. Intermediate-Acting Insulin
        3. Long-Acting Insulin
        4. Short-Acting Insulin
        5. Premixed-Type Insulin
      4. U.K.
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      5. Germany
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      6. France
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      7. Spain
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      8. Italy
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      9. Russia
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      10. Nordic
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      11. Benelux
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      12. Rest of Europe
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
    3. APAC
      1. APAC Smart Insulin or Glucose Responsive Insulin Market By Delivery Device 2022-2034 (USD MILLION/ Units)
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
      2. APAC Smart Insulin or Glucose Responsive Insulin Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. APAC Smart Insulin or Glucose Responsive Insulin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rapid-Acting Insulin
        2. Intermediate-Acting Insulin
        3. Long-Acting Insulin
        4. Short-Acting Insulin
        5. Premixed-Type Insulin
      4. China
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      5. Korea
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      6. Japan
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      7. India
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      8. Australia
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      9. Taiwan
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      10. South East Asia
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      11. Rest of Asia-Pacific
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
    4. Middle East and Africa
      1. Middle East and Africa Smart Insulin or Glucose Responsive Insulin Market By Delivery Device 2022-2034 (USD MILLION/ Units)
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
      2. Middle East and Africa Smart Insulin or Glucose Responsive Insulin Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. Middle East and Africa Smart Insulin or Glucose Responsive Insulin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rapid-Acting Insulin
        2. Intermediate-Acting Insulin
        3. Long-Acting Insulin
        4. Short-Acting Insulin
        5. Premixed-Type Insulin
      4. UAE
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      5. Turkey
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      6. Saudi Arabia
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      7. South Africa
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      8. Egypt
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      9. Nigeria
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      10. Rest of MEA
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
    5. LATAM
      1. LATAM Smart Insulin or Glucose Responsive Insulin Market By Delivery Device 2022-2034 (USD MILLION/ Units)
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
      2. LATAM Smart Insulin or Glucose Responsive Insulin Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Type 1 Diabetes
        2. Type 2 Diabetes
      3. LATAM Smart Insulin or Glucose Responsive Insulin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rapid-Acting Insulin
        2. Intermediate-Acting Insulin
        3. Long-Acting Insulin
        4. Short-Acting Insulin
        5. Premixed-Type Insulin
      4. Brazil
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      5. Mexico
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      6. Argentina
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      7. Chile
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      8. Colombia
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
      9. Rest of LATAM
        1. Smart Insulin Pens
        2. Smart Insulin Pumps
        3. Type 1 Diabetes
        4. Type 2 Diabetes
        5. Rapid-Acting Insulin
        6. Intermediate-Acting Insulin
        7. Long-Acting Insulin
        8. Short-Acting Insulin
        9. Premixed-Type Insulin
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.